ASA CHEESMAN: Open Payments
NPI 1497208482 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$213 in 10 payments from 5 companies in 2025. Trend: 2023 $722 · 2024 $346 · 2025 $213
Food & beverage: $213
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $68 |
| Alkermes, Inc. | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: ARISTADA, UZEDY, ABILIFY ASIMTUFII, INVEGA SUSTENNA, AUSTEDO XR, FANAPT.
Industry payments across NY — which companies pay providers there.
